Pharmaceuticals - Community Register


Community list of not active medicinal products for human use


Product information

Invented name: Possia
Auth. number : EU/1/10/656
Active substance : ticagrelor
ATC: Anatomical main group: B - Blood and blood forming organs
Therapeutic subgroup: B01 - Antithrombotic agents
Pharmacological subgroup: B01A - Antithrombotic agents
Chemical subgroup: B01AC - Platelet aggregation inhibitors excluding Heparin
Chemical substance: B01AC24 - ticagrelor
(See WHO ATC Index)
Indication: the prevention of atherothrombotic events in adult patients with Acute Coronary Syndromes (unstable angina, non ST elevation Myocardial Infarction [NSTEMI] or ST elevation Myocardial Infarction [STEMI])
Marketing Authorisation Holder: AstraZeneca AB
151 85 Södertälje, Sverige
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/12/2010 Centralised - Authorisation EMEA/H/C/2303 (2010)8907 of 03/12/2010
26/10/2011 Centralised - Variation EMEA/H/C/2303/IB/1
Updated with Decision(2012)3295 of 14/05/2012
16/05/2012 Centralised - Variation (2012)3295 of 14/05/2012
26/10/2012 Centralised - Variation EMEA/H/C/2303/WS/292 (2012)7651 of 24/10/2012
02/04/2013 Centralised - Withdrawal (2013)1971 of 27/03/2013